341 related articles for article (PubMed ID: 30636622)
1. Oxidative and Inflammatory Events in Prion Diseases: Can They Be Therapeutic Targets?
Prasad KN; Bondy SC
Curr Aging Sci; 2019; 11(4):216-225. PubMed ID: 30636622
[TBL] [Abstract][Full Text] [Related]
2. Neurometals in the Pathogenesis of Prion Diseases.
Kawahara M; Kato-Negishi M; Tanaka KI
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525334
[TBL] [Abstract][Full Text] [Related]
3. A receptor for infectious and cellular prion protein.
Martins VR
Braz J Med Biol Res; 1999 Jul; 32(7):853-9. PubMed ID: 10454744
[TBL] [Abstract][Full Text] [Related]
4. Altered distribution, aggregation, and protease resistance of cellular prion protein following intracranial inoculation.
Ward A; Hollister JR; Choi YP; Race B; Williams K; Shoup DW; Moore RA; Priola SA
PLoS One; 2019; 14(7):e0219457. PubMed ID: 31291644
[TBL] [Abstract][Full Text] [Related]
5. Folding and misfolding of the prion protein in the secretory pathway.
Tatzelt J; Winklhofer KF
Amyloid; 2004 Sep; 11(3):162-72. PubMed ID: 15523918
[TBL] [Abstract][Full Text] [Related]
6. Fundamentals of prion diseases and their involvement in the loss of function of cellular prion protein.
Sakudo A; Ikuta K
Protein Pept Lett; 2009; 16(3):217-29. PubMed ID: 19275734
[TBL] [Abstract][Full Text] [Related]
7. Prion-induced neuronal damage--the mechanisms of neuronal destruction in the subacute spongiform encephalopathies.
Giese A; Kretzschmar HA
Curr Top Microbiol Immunol; 2001; 253():203-17. PubMed ID: 11417136
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress and neurodegeneration in prion diseases.
Kim JI; Choi SI; Kim NH; Jin JK; Choi EK; Carp RI; Kim YS
Ann N Y Acad Sci; 2001 Apr; 928():182-6. PubMed ID: 11795509
[TBL] [Abstract][Full Text] [Related]
9. Identification of a homology-independent linchpin domain controlling mouse and bank vole prion protein conversion.
Burke CM; Mark KMK; Walsh DJ; Noble GP; Steele AD; Diack AB; Manson JC; Watts JC; Supattapone S
PLoS Pathog; 2020 Sep; 16(9):e1008875. PubMed ID: 32898162
[TBL] [Abstract][Full Text] [Related]
10. Insight into the PrPC-->PrPSc conversion from the structures of antibody-bound ovine prion scrapie-susceptibility variants.
Eghiaian F; Grosclaude J; Lesceu S; Debey P; Doublet B; Tréguer E; Rezaei H; Knossow M
Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10254-9. PubMed ID: 15240887
[TBL] [Abstract][Full Text] [Related]
11. Microglia and prion disease: a review.
Brown DR; Kretzschmar HA
Histol Histopathol; 1997 Jul; 12(3):883-92. PubMed ID: 9225170
[TBL] [Abstract][Full Text] [Related]
12. Prion diseases and the 'protein only' hypothesis: a theoretical dynamic study.
Laurent M
Biochem J; 1996 Aug; 318 ( Pt 1)(Pt 1):35-9. PubMed ID: 8761449
[TBL] [Abstract][Full Text] [Related]
13. Photo-induced crosslinking of prion protein oligomers and prions.
Piening N; Weber P; Högen T; Beekes M; Kretzschmar H; Giese A
Amyloid; 2006 Jun; 13(2):67-77. PubMed ID: 16911960
[TBL] [Abstract][Full Text] [Related]
14. Neurodegeneration and oxidative stress: prion disease results from loss of antioxidant defence.
Brown DR
Folia Neuropathol; 2005; 43(4):229-43. PubMed ID: 16416388
[TBL] [Abstract][Full Text] [Related]
15. The cellular prion protein: biochemistry, topology, and physiologic functions.
Griffoni C; Toni M; Spisni E; Bianco M; Santi S; Riccio M; Tomasi V
Cell Biochem Biophys; 2003; 38(3):287-304. PubMed ID: 12794269
[TBL] [Abstract][Full Text] [Related]
16. Bile Acids Reduce Prion Conversion, Reduce Neuronal Loss, and Prolong Male Survival in Models of Prion Disease.
Cortez LM; Campeau J; Norman G; Kalayil M; Van der Merwe J; McKenzie D; Sim VL
J Virol; 2015 Aug; 89(15):7660-72. PubMed ID: 25972546
[TBL] [Abstract][Full Text] [Related]
17. Molecular Mechanism of the Misfolding and Oligomerization of the Prion Protein: Current Understanding and Its Implications.
Singh J; Udgaonkar JB
Biochemistry; 2015 Jul; 54(29):4431-42. PubMed ID: 26171558
[TBL] [Abstract][Full Text] [Related]
18. Loss of prion protein control of glucose metabolism promotes neurodegeneration in model of prion diseases.
Arnould H; Baudouin V; Baudry A; Ribeiro LW; Ardila-Osorio H; Pietri M; Caradeuc C; Soultawi C; Williams D; Alvarez M; Crozet C; Djouadi F; Laforge M; Bertho G; Kellermann O; Launay JM; Schmitt-Ulms G; Schneider B
PLoS Pathog; 2021 Oct; 17(10):e1009991. PubMed ID: 34610054
[TBL] [Abstract][Full Text] [Related]
19. Molecular clues to pathogenesis in prion diseases.
Laurent M; Johannin G
Histol Histopathol; 1997 Apr; 12(2):583-94. PubMed ID: 9151145
[TBL] [Abstract][Full Text] [Related]
20. Trace elements and prion diseases: a review of the interactions of copper, manganese and zinc with the prion protein.
Leach SP; Salman MD; Hamar D
Anim Health Res Rev; 2006; 7(1-2):97-105. PubMed ID: 17389057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
